[go: up one dir, main page]

BRPI0818121A2 - diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização - Google Patents

diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização

Info

Publication number
BRPI0818121A2
BRPI0818121A2 BRPI0818121A BRPI0818121A BRPI0818121A2 BR PI0818121 A2 BRPI0818121 A2 BR PI0818121A2 BR PI0818121 A BRPI0818121 A BR PI0818121A BR PI0818121 A BRPI0818121 A BR PI0818121A BR PI0818121 A2 BRPI0818121 A2 BR PI0818121A2
Authority
BR
Brazil
Prior art keywords
diespiro
trioxolane
manufacture
methods
Prior art date
Application number
BRPI0818121A
Other languages
English (en)
Inventor
Darren J Creek
Hugues Matile
Jacques Chollet
Jonathan L Vennerstrom
Kamaraj Sriraghavan
Lin Zhon
Sergio Wittlin
Susan A Charman
William N Charman
Xiaofang Wang
Yuxiang Dong
Original Assignee
Medicines Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines Malaria Venture Mmv filed Critical Medicines Malaria Venture Mmv
Publication of BRPI0818121A2 publication Critical patent/BRPI0818121A2/pt
Publication of BRPI0818121B1 publication Critical patent/BRPI0818121B1/pt
Publication of BRPI0818121B8 publication Critical patent/BRPI0818121B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0818121A 2007-10-31 2008-10-29 diespiro 1,2,4-trioxolano e composição farmacêutica contendo o mesmo BRPI0818121B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/930,606 US8067620B2 (en) 2005-05-04 2007-10-31 Dispiro 1,2,4-trioxolane antimalarials
US11/930,606 2007-10-31
PCT/US2008/081579 WO2009058859A2 (en) 2007-10-31 2008-10-29 Dispiro 1,2,4-trioxolane antimalarials

Publications (3)

Publication Number Publication Date
BRPI0818121A2 true BRPI0818121A2 (pt) 2015-11-17
BRPI0818121B1 BRPI0818121B1 (pt) 2020-12-08
BRPI0818121B8 BRPI0818121B8 (pt) 2021-05-25

Family

ID=40228026

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818121A BRPI0818121B8 (pt) 2007-10-31 2008-10-29 diespiro 1,2,4-trioxolano e composição farmacêutica contendo o mesmo

Country Status (19)

Country Link
US (1) US8067620B2 (pt)
EP (1) EP2203457B1 (pt)
JP (1) JP5559057B2 (pt)
KR (1) KR101588468B1 (pt)
CN (1) CN101842377B (pt)
AU (1) AU2008318819C1 (pt)
BR (1) BRPI0818121B8 (pt)
CA (1) CA2702256C (pt)
CY (1) CY1115148T1 (pt)
DK (1) DK2203457T3 (pt)
ES (1) ES2466319T3 (pt)
HR (1) HRP20140435T1 (pt)
MX (1) MX2010004601A (pt)
PL (1) PL2203457T3 (pt)
PT (1) PT2203457E (pt)
RU (1) RU2493159C2 (pt)
SI (1) SI2203457T1 (pt)
UA (1) UA99742C2 (pt)
WO (1) WO2009058859A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
WO2012106190A1 (en) 2011-01-31 2012-08-09 Bristol-Myers Squibb Company C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
EA201492291A1 (ru) * 2012-06-13 2015-05-29 Медицинише Универзитет Вин Амидофеноксипропаноламины
US10287312B2 (en) 2014-02-14 2019-05-14 The Regents Of The University Of California Cyclic peroxides as prodrugs for selective delivery of agents
EP3309156A1 (en) 2016-10-13 2018-04-18 MMV Medicines for Malaria Venture New anti-malarial agents
JP2019530712A (ja) 2016-10-13 2019-10-24 エムエムヴィ メディシンズ フォア マラリア ヴェンチャーＭｍｖ Ｍｅｄｉｃｉｎｅｓ Ｆｏｒ Ｍａｌａｒｉａ Ｖｅｎｔｕｒｅ 新規抗マラリア薬
US11246854B2 (en) 2017-05-16 2022-02-15 The Johns Hopkins University Ozonides for treating or preventing virus infections
WO2019005977A1 (en) 2017-06-27 2019-01-03 The Regents Of The University Of California TRIOXOLANE AGENTS
CN110878069A (zh) * 2019-12-09 2020-03-13 南京杰运医药科技有限公司 一种4-吗琳基-2-乙基哌嗪的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621062A (en) 1966-10-25 1971-11-16 Sterling Drug Inc 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol
US3673222A (en) 1969-11-26 1972-06-27 Sydney Archer 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof
US3682991A (en) 1970-10-19 1972-08-08 Sterling Drug Inc 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US4916204A (en) 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4816478A (en) 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
US5053342A (en) 1987-12-24 1991-10-01 Litmus Concepts, Inc. Fecal occult blood test reagents
US5559145A (en) 1988-06-01 1996-09-24 Oxaco S.A. 1,2,4-trioxane derivatives
US5270344A (en) 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
JP2867529B2 (ja) 1990-01-22 1999-03-08 三菱電機株式会社 投写型表示装置
US5216175A (en) 1990-03-23 1993-06-01 Sri International Antimalarial analogs of artemisinin
US5219880A (en) 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5510356A (en) 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
US5171676A (en) 1991-10-31 1992-12-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of introducing hydroxyl groups into artemisinin and its derivatives
US5430148A (en) 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
CA2141192C (en) 1992-07-28 1999-02-02 Roberta C. Bloom Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5721209A (en) 1995-02-03 1998-02-24 The Regents Of The University Of California Iron chelator and inhibitor of iron-mediated oxidant injury
US5780675A (en) 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
US5578637A (en) 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5672624A (en) 1995-11-22 1997-09-30 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5817692A (en) 1995-11-22 1998-10-06 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5932591A (en) 1996-12-02 1999-08-03 Johns Hopkins University C3 substituted trioxanes useful as antiparasitic drugs
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US8067620B2 (en) 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
ES2615458T3 (es) * 2005-05-18 2017-06-07 Sun Pharmaceutical Industries Limited Formas de dosificación estables de antimaláricos de espiro y dispiro 1,2,4 trioxolano

Also Published As

Publication number Publication date
AU2008318819A1 (en) 2009-05-07
CA2702256A1 (en) 2009-05-07
RU2010121919A (ru) 2011-12-10
WO2009058859A3 (en) 2009-06-18
MX2010004601A (es) 2010-05-27
BRPI0818121B8 (pt) 2021-05-25
DK2203457T3 (da) 2014-05-12
PL2203457T3 (pl) 2014-08-29
US20080125411A1 (en) 2008-05-29
EP2203457B1 (en) 2014-03-05
HK1147092A1 (en) 2011-07-29
CA2702256C (en) 2017-09-26
CY1115148T1 (el) 2016-12-14
KR20100087199A (ko) 2010-08-03
JP2011502131A (ja) 2011-01-20
US8067620B2 (en) 2011-11-29
KR101588468B1 (ko) 2016-01-25
WO2009058859A2 (en) 2009-05-07
SI2203457T1 (sl) 2014-06-30
RU2493159C2 (ru) 2013-09-20
BRPI0818121B1 (pt) 2020-12-08
CN101842377A (zh) 2010-09-22
CN101842377B (zh) 2015-07-01
JP5559057B2 (ja) 2014-07-23
HRP20140435T1 (hr) 2014-06-20
ES2466319T3 (es) 2014-06-17
PT2203457E (pt) 2014-06-06
UA99742C2 (en) 2012-09-25
EP2203457A2 (en) 2010-07-07
AU2008318819B2 (en) 2013-11-21
AU2008318819C1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
NL301192I2 (nl) Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan
BRPI0813244A2 (pt) Compostos e seus usos 708
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
BRPI0812367A2 (pt) Dispositivos interoclusais e respectivos métodos de fabrico
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
EP2153838A4 (en) ANTI-NOROVIRUS AGENT AND COMPOSITION COMPRISING SAME
BRPI0806941A2 (pt) Implementos de higiene bucal que têm elementos flexíveis, e métodos de produção dos mesmos
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
DE602006004866D1 (de) Katheter
BRPI0618398A2 (pt) artigo absorvente
BRPI0906387A2 (pt) Anticorpos alfa 5 - beta 1 e seus usos
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0814330A2 (pt) métodos e kits cirúrgicos
HRP20141261T1 (xx) Spojevi tioninija i njihove uporabe
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização
ZA201003290B (en) Keratin derivatives and methods of making the same
BRPI0618396A2 (pt) artigo absorvente
JP2006122056A5 (ja) β-グルカンの使用
DK2078038T3 (da) Rekonstituerede surfaktanter med forbedrede egenskaber
BRPI0821351A2 (pt) aparelhos e métodos
SMT201500273B (it) Diidroetorfine e loro preparazione
ATE541462T1 (de) Insektizide kombinationen umfassend abamectin und cyflumetofen
NO20055643D0 (no) Preparation of lodixanol

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MMV MEDICINES FOR MALARIA VENTURE (CH)

B25G Requested change of headquarter approved

Owner name: MMV MEDICINES FOR MALARIA VENTURE (CH)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF